A growing body of evidence has suggested that KLF7 is associated with human obesity, type II diabetes and cardiovascular diseases, and KLF7 is one of five specific core transcription factors that regulate coronary artery disease associated pathways36–38. Here, KLF7 is linked to cardiovascular disorder.